Traws Pharma, Inc. (TRAW)
NASDAQ: TRAW · Real-Time Price · USD
2.460
-0.360 (-12.77%)
At close: Jan 28, 2026, 4:00 PM EST
2.490
+0.030 (1.22%)
After-hours: Jan 28, 2026, 4:53 PM EST

Traws Pharma Revenue

Traws Pharma had revenue of $2.85M in the twelve months ending September 30, 2025, up 1,159.29% year-over-year. In the year 2024, Traws Pharma had annual revenue of $226.00K.

Revenue (ttm)
$2.85M
Revenue Growth
+1,159.29%
P/S Ratio
6.60
Revenue / Employee
$406,571
Employees
7
Market Cap
19.66M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024226.00K--
Dec 31, 2023226.00K--
Dec 31, 2022226.00K--
Dec 31, 2021226.00K-5.00K-2.16%
Dec 31, 2020231.00K-1.95M-89.42%
Dec 31, 20192.18M955.00K77.77%
Dec 31, 20181.23M441.00K56.04%
Dec 31, 2017787.00K-4.76M-85.81%
Dec 31, 20165.55M-5.91M-51.59%
Dec 31, 201511.46M10.66M1,332.00%
Dec 31, 2014800.00K-3.95M-83.17%
Dec 31, 20134.75M-41.44M-89.71%
Dec 31, 201246.19M44.70M3,006.25%
Dec 31, 20111.49M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
CASI Pharmaceuticals26.85M
BioAtla11.00M
VYNE Therapeutics524.00K
Lexaria Bioscience522.00K
Iterum Therapeutics390.00K
Revenue Rankings